Kristiina Takkinen

This inventor holds 10 USPTO granted patents and 6 published patent applications, plus 6 CIPO patents and 5 EPO patents. Top assignees: Valtion Teknillinen Tutkimuskeskus, Desentum Oy, Teknologian Tutkimuskeskus Vtt. Active years: 1997-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kristiina Takkinen. Retrieved from https://idiyas.com/inventor/kristiina-takkinen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10 (Patent Applications = 6)

% Patents Active = 70.0

CIPO Patents = 6 (Patent Applications = 5)

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 43(Granted Patents)

Company Filing History:

4 out of 152

Valtion Teknillinen Tutkimuskeskus

Teknologian Tutkimuskeskus Vtt

Years Active: 1997-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11679152 - Recombinant hypoallergenic Equ c 1 polypeptides for use in the immunotherapy of horse allergy (2023-06-20),

2. 9856296 - Hypoallergen (2018-01-02),

3. 9416401 - Method for determining amounts of polynucleotide sequences present in cell or tissue samples (2016-08-16),

4. 9261511 - Allergen-binding IgE monoclonal antibodies and method for preparing hypoallergens (2016-02-16),

5. 8877894 - Modified beta-lactoglobulins for immunotherapy of milk allergy (2014-11-04),

6. 8518653 - Detection of cannabis use (2013-08-27),

7. 8143388 - Method and test kit for quantitative determination of polynucleotides in a mixture (2012-03-27),

8. 7749712 - Non-competitive immunoassay for small analytes (2010-07-06),

9. 7361461 - Method and test kit for quantitative determination of polynucleotides in a mixture (2008-04-22),

10. 5610034 - Immunoglobulin production by trichoderma (1997-03-11),

Title: Innovations of Kristiina Takkinen

Introduction

Kristiina Takkinen is a prominent inventor based in Espoo, Finland. She has made significant contributions to the field of immunotherapy, particularly in developing hypoallergenic polypeptides for treating allergies. With a total of 10 patents to her name, Takkinen's work is paving the way for advancements in allergy treatments.

Latest Patents

One of her latest patents is focused on recombinant hypoallergenic Equ c 1 polypeptides for use in the immunotherapy of horse allergy. This invention relates to specific modified Equ c 1 polypeptides that serve as hypoallergens for desensitizing individuals against horse allergies. The recombinant hypoallergenic polypeptide activates the release of histamine from basophils to a lesser degree than the wild type allergen. Another significant patent involves mutant polypeptides that are useful as hypoallergens, specifically mutant Bet v 1 proteins, which are aimed at desensitizing individuals against birch pollen allergies. This invention also includes vaccine formulations comprising such polypeptides and methods of vaccination against birch pollen allergy.

Career Highlights

Throughout her career, Kristiina Takkinen has worked with notable organizations, including Valtion Teknillinen Tutkimuskeskus and Desentum Oy. Her innovative research and development efforts have significantly impacted the field of allergy treatment.

Collaborations

Takkinen has collaborated with esteemed colleagues such as Hans Söderlund and Juha Rouvinen, contributing to her success in the field.

Conclusion

Kristiina Takkinen's work in developing hypoallergenic polypeptides showcases her dedication to improving allergy treatments. Her innovative patents and collaborations highlight her significant role in advancing immunotherapy.

Profile summary based on public USPTO records.